NCT04804345View on ClinicalTrials.gov

AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding

CompletedOBSERVATIONAL
Enrollment

693

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Cardiac SurgeryCardiopulmonary BypassHigh Risk Bleeding
Interventions
OTHER

standard of care

retrospective study: standard of care

Trial Locations (7)

33604

Bordeaux University Hospital, Pessac

34295

Montpellier University Hospital, Montpellier

38700

Grenoble University Hospital, La Tronche

44093

Nantes University Hospital, Nantes

69500

Lyon University Hospital, Lyon

75877

North Val de Seine Paris University Hospital, Paris

75908

Georges Pompidou European University Hospital, Paris

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04804345 - AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding | Biotech Hunter | Biotech Hunter